Clinical Trial Update: Dimethyldiguanide Combined With Aromatase Inhibitor (AI) in Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

This document reports a completed Phase 2 clinical trial evaluating dimethyldiguanide in combination with an aromatase inhibitor for metastatic breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Aromatase inhibitor (unspecified) (aromatase inhibitor)
• Dimethyldiguanide (Dimethyldiguanide)

Snippet

Sponsor: Xichun Hu | Conditions: Metastatic Breast Cancer | Phase 2 | Status: COMPLETED